Company news
Senseonics Holdings, Inc. (NASDAQ:SENS) news
Every Senseonics Holdings, Inc. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Senseonics Announces Strategic Partnership with Beta Bionics to Integrate Eversense® 365 with the iLet® Bionic Pancreas
September 14, 2026
Senseonics To Participate in Upcoming Institutional Investor Conferences
September 10, 2026
Sensus Healthcare Reports Second Quarter 2026 Financial Results and Business Highlights
August 13, 2026
Senseonics Holdings, Inc. Reports Second Quarter 2026 Financial Results
August 6, 2026
Senseonics Holdings, Inc. Schedules Second Quarter 2026 Earnings Release and Conference Call for August 6, 2026 at 4:30 P.M. Eastern Time
July 21, 2026
Senseonics and Welldoc Partner to Develop Next-Generation App for Eversense® 365
June 10, 2026
Real-World Evidence of Eversense 365 Presented at ADA Demonstrating Strong Performance and Patient Impact in Both Open and Closed Loop Sy...
June 6, 2026
SENS short-form announcement: year-end results (Short form report year end results)
June 2, 2026
Senseonics Highlights Analyst Event and Oral Presentation of Eversense 365 Real-World Evidence at ADA 2026
June 1, 2026
XCF Global Backs Southern Energy Renewables' LOI With Hapag-Lloyd for Green Methanol Project Development and Long-Term Offtake as Strateg...
May 13, 2026
Senseonics Holdings, Inc. Reports First Quarter 2026 Financial Results
May 7, 2026
Senseonics Announces Closing of $92 Million Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
May 4, 2026
Senseonics Holdings, Inc. Schedules First Quarter 2026 Earnings Release and Conference Call for May 7, 2026 at 4:30 P.M. Eastern Time
May 1, 2026
Senseonics Announces Pricing of $80 Million Public Offering of Common Stock and Pre-Funded Warrants
April 30, 2026
Senseonics Announces Commencement of $80 Million Public Offering of Common Stock and Pre-Funded Warrants
April 30, 2026
Senseonics Announces European Launch of Eversense 365, The World's First and Only One Year CGM System
April 27, 2026
Senseonics Announces European Launch of Eversense® 365, The World’s First and Only One Year CGM System
April 24, 2026
First Ever Real-World Evidence of Eversense 365 Presented at ATTD Demonstrates Sustained Performance and Positive Impact Throughout One-Y...
March 14, 2026
Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results
March 2, 2026
Sequel Med Tech and Senseonics Launch Transformative Combination of twiist™ and Eversense® 365
February 19, 2026
Senseonics Receives European Approval for Eversense 365, World’s Longest-lasting Continuous Glucose Monitor
January 29, 2026
Senseonics Holdings, Inc. to Participate at the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
January 28, 2026
Senseonics Announces Preliminary Unaudited Revenue for Fourth Quarter 2025 and Provides Business Update
January 12, 2026
Senseonics Announces First Commercial Patients Using Eversense 365 Continuous Glucose Monitor (CGM) with twiist™ Automated Insulin Delive...
January 8, 2026
Senseonics Holdings, Inc. to Participate in the Stifel 2025 Healthcare Conference
November 10, 2025
Senseonics Announces Transfer to Nasdaq Stock Exchange
November 10, 2025
Senseonics Holdings, Inc. Reports Third Quarter Financial Results
November 5, 2025
Senseonics Holdings, Inc. Schedules Third Quarter 2025 Earnings Release and Conference Call for November 5, 2025 at 4:30 P.M. Eastern Time
October 22, 2025
Senseonics Announces Preliminary Unaudited Revenue for Third Quarter 2025 and Provides Business Update
October 6, 2025
Senseonics Signs Memorandum of Understanding with Ascensia Diabetes Care to Take Over Commercialization and Distribution of Eversense 365
September 3, 2025
Senseonics Holdings, Inc. Reports Second Quarter Financial Results
August 6, 2025
Senseonics Holdings, Inc. Schedules Second Quarter 2025 Earnings Release and Conference Call for August 6, 2025 at 4:30 P.M. Eastern Time
July 16, 2025
Senseonics Holdings, Inc. to Host In-Person and Virtual Analyst Event at ADA 2025: Eversense® 365 Continuous Glucose Monitoring System fo...
June 4, 2025
Senseonics Holdings, Inc. Announces Closing of Public Offering, Including Exercise in Full of the Underwriters’ Option to Purchase Additi...
May 21, 2025
Senseonics Announces Commencement of $50 Million Public Offering of Common Stock and Concurrent Private Placement
May 15, 2025
Senseonics Announces Pricing of $50 Million Public Offering of Common Stock and Concurrent Private Placement
May 15, 2025
Senseonics Holdings, Inc. Reports First Quarter Financial Results
May 8, 2025
Senseonics Holdings, Inc. Schedules First Quarter 2025 Earnings Release and Conference Call for May 8, 2025 at 4:30 P.M. Eastern Time
April 29, 2025
Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results
March 3, 2025
Senseonics Holdings, Inc. Schedules Fourth Quarter and Full Year 2024 Earnings Release and Conference Call for March 3, 2025 at 4:30 P.M....
February 12, 2025
Senseonics Completes CE Mark Submission for Eversense 365, World’s Longest-lasting Continuous Glucose Monitor
February 6, 2025
Senseonics Holdings, Inc. Announces Business Updates Including Preliminary 2024 Results, 365 Launch Update and Cancellation of Special Me...
January 8, 2025
Senseonics Holdings, Inc. Provides Update on Eversense 365 Launch
December 9, 2024
Senseonics Holdings, Inc. Reports Third Quarter 2024 Financial Results
November 7, 2024
Senseonics Holdings, Inc. Announces $16 Million Registered Direct Offering
October 25, 2024
Senseonics Holdings, Inc. Schedules Third Quarter 2024 Earnings Release and Conference Call for November 7, 2024 at 4:30 P.M. Eastern Time
October 24, 2024
Senseonics to Host Virtual KOL Event on Eversense 365: FDA Clearance and Commercialization Plans for the World's First One-Year CGM System
October 16, 2024
Mercy Places First Commercial Eversense 365: The World's First and Only 365-Day Continuous Glucose Monitor
October 10, 2024
Eversense 365 Launches in the US: One Year. One CGM.
October 1, 2024
Eversense 365 Receives FDA Clearance: The World’s First One Year CGM
September 17, 2024